News Sentiment

RLAY sentiment intelligence

Relay Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 66 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 20.01 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 58

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+7.3% over one week, +35.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Canaccord initiates Relay Therapeutics stock with buy rating

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction 7.3% Price confirming higher
Trend fit Trend active 35.1% over four weeks
Fair value 164.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 38
Negative 12

Relevance

Why the article matched

Direct first
Direct company coverage 58
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
Investing.com 7
Stock Titan 7
TradingView 6
simplywall.st 6
MT Newswires 3
GlobeNewswire 3
Moomoo 2

Event Lens

What the news is about

Classified themes
Market update 38
Earnings 15
Analyst action 8
Deals and strategy 2
Balance sheet 2
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 66
www.marketscreener.com Direct company coverage

Relay Therapeutics, Inc.(NasdaqGM:RLAY) added to Russell Small Cap Comp Growth Benchmark

Relay Therapeutics, Inc. (NasdaqGM:RLAY) has been added to the Russell Small Cap Comp Growth Benchmark. This inclusion is significant for the clinical-stage biotechnology company, which focuses on developing small molecule precision medicines for cancer and genetic diseases using

Tone
Positive 74/100
Event
Market update
Published
29 Jun 2026 21:39
Source
www.marketscreener.com
Stocktwits Direct company coverage

Why Is RLAY Stock Rising Today?

Relay Therapeutics (RLAY) shares surged by 10% in pre-market trading after announcing positive early-stage clinical data for Zovegalisib, its experimental treatment for vascular anomalies. The study showed strong efficacy with 60% of evaluable patients achieving significant lesio

Tone
Positive 93/100
Event
Market update
Published
26 Jun 2026 16:40
Source
Stocktwits
TradingView Direct company coverage

Relay Therapeutics, Inc. Actuals & Estimates (NASDAQ:RLAY)

This article provides an overview of Relay Therapeutics, Inc. (NASDAQ: RLAY) stock performance, forecasts, and financial data. It details the current stock price, historical highs and lows, market capitalization, volatility, and upcoming earnings report. The piece also includes a

Tone
Positive 70/100
Event
Earnings
Published
26 Jun 2026 15:09
Source
TradingView
MarketBeat Direct company coverage

Relay Therapeutics (RLAY) Short Interest & Short Float | Updated Jun 2026 $RLAY

As of June 15, 2026, Relay Therapeutics (RLAY) had a short interest of 38.12 million shares, representing 20.96% of its public float, marking a 10.86% increase from the prior report. The short interest ratio is 9.9 days to cover. This data indicates a significant bearish sentimen

Tone
Negative 34/100
Event
Market update
Published
26 Jun 2026 03:40
Source
MarketBeat
TradingView Direct company coverage

RLAY Forecast — Price Target — Prediction for 2027

Relay Therapeutics, Inc. (RLAY) stock has seen significant growth, rising 465.34% over the last year. Analysts have provided price forecasts for RLAY, with a maximum estimate of $32.00 and a minimum of $20.00. The company is set to release its next earnings report on August 6, 20

Tone
Positive 65/100
Event
Earnings
Published
26 Jun 2026 03:39
Source
TradingView